T1	Participants 36 66	HIV risk reduction among women
T2	Participants 98 168	333 seronegative African American female drug users (aged 18-59 years)
T3	Participants 399 515	Participants were recruited between June 1998 and January 2001 from inner-city Atlanta (Georgia, U.S.) neighborhoods
